Ipriflavone
Overview
Ipriflavone is a synthetic isoflavonoid that inhibits reabsorption of bone. Ipriflavone is given by mouth and is available for the treatment of osteoporosis.
Categories
- 18 Hormones and other endocrine drugs and contraceptives
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Ipriflavone's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 400 to 600 | 500 (500) | As recommended. | | |
| 600 to 1200 mg | 900 (900) | As recommended. | | Paget''s disease weak bones due to lidney disease. |
| 200 mg | 200 (200) | 8 hourly | PO | Postmenopavsal osteoporosis. |
Paedriatic Dosage (20kg)
|
| | | | Not recommended in this age group |
Neonatal Dosage (3kg)
|
| | | | Not recommended in this age group |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Ipriflavone
Back to top
Previous Drug Generic - Next Drug Generic